Delivery Order SPE2DB20D2002-SPE2DB25FL66W
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a contract ceiling value of $2,603.50. This delivery order represents a firm fixed-price procurement with an ultimate completion date of August 21, 2025, and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units, with a ceiling value of $12,332.70 and firm fixed pricing. This non-set-aside competitive delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Azithromycin 500 mg tablets (30-count packaging) with a ceiling value of $9,828.00. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a ceiling value of $6,311.42. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on capability. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Azithromycin 250 mg tablets in packages of six units. This contract, valued at $6,924.89, represents a firm fixed-price delivery order with an ultimate completion date of May 5, 2025. The award was made through open competition with no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $73,152.00 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as...
- The Defense Logistics Agency awarded a $2,279.96 delivery order to AmerisourceBergen Drug Corp for Azithromycin 250 mg tablets on April 24, 2025, with completion scheduled for April 25, 2025. This order represents a competitive, non-set-aside contract utilizing firm fixed pricing under a delivery order vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a $1,526.00 delivery order to AmerisourceBergen Drug Corp for Azithromycin 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.88 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Azithromycin 250 mg tablets (packaged as 6-unit strips). This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This delivery order, valued at $1,255.04 with a firm fixed price structure, represents a non-competitive set-aside award and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL66WDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 per unit, with a ceiling value of $8,271.78. This competitive award, issued without set-aside designation, is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense Logistics Agency, executed under the company's broader Indefinite Delivery Contract valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for the DLA Troop Support Medical supply chain, delivering a comprehensive portfolio of generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs and defense systems globally. The company's status as a prime vendor reflects its capability to meet federal medical procurement requirements through competitive procurement processes and its established role in supporting Defense Health Agency and broader government healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/14/25 |